Companies that own MorphoSys AG
Fidelity Management & Research Co.
2,904,455
9.11%
510,928
0.04%
07/20/2018
OppenheimerFunds, Inc.
1,482,749
4.66%
-1,492
0.1%
04/18/2018
Baillie Gifford & Co.
1,267,457
3.98%
0
0.09%
03/09/2018
Consonance Capital Management LP
965,355
3.03%
965,355
6.11%
03/13/2018
Templeton Investment Counsel LLC
948,062
2.98%
126,827
0.52%
05/14/2018
Schroder Investment Management Ltd.
945,390
2.97%
-38,686
0.07%
07/11/2018
Templeton Global Advisors Ltd.
905,532
2.84%
-809,618
0.27%
05/22/2018
The Vanguard Group, Inc.
791,306
2.49%
8,317
0%
07/31/2018
Invesco Advisers, Inc.
700,937
2.2%
700,937
0.05%
03/09/2018
BVF Partners LP
684,942
2.15%
-531,020
5.46%
11/08/2017
| Address |
Semmelweisstraße 7
Planegg Bayern (Bavaria) 82152
Germany
|
|
Employees
|
- |
| Website |
http://www.morphosys.de |
| Updated |
07/08/2019 |
| MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. |
